See our guides: Medicaid 13 states cover for obesity (state-dependent) TRICARE Covers with BMI 30 and documented comorbidity Humana Medicare Advantage plans may cover UnitedHealthcare Some MA plans include coverage Aetna Commercial plans often cover with PA Other GLP-1 Medications on Medicare Medicare coverage varies by medication
Each of the different brands of semaglutide (Wegovy, Ozempic, Rybelus) is FDA approved for different conditions
MassHealth began covering certain obesity medications in January 2024
During the tirzepatide shortage period (roughly mid-2023 through late 2024), compounding pharmacies were permitted under FDA enforcement discretion to produce copies of commercially available tirzepatide to help meet patient demand
For a standard 5mg/mL semaglutide vial : 0.25mg = 5 units on an insulin syringe 0.5mg = 10 units 1.0mg = 20 units 1.7mg = 34 units 2.0mg = 40 units For a higher concentration vial , the unit count changes proportionally
Quick Answer: Yes, you can generally have weight loss injections after gallbladder removal, as cholecystectomy is not a contraindication for GLP-1 receptor agonists